T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INOV
2151
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $445K | ﹤0.01% |
30,689
+158
| +0.5% | +$2.14K |
|
2152
Banc of California
BANC
$3.1B
| $443K | ﹤0.01% |
31,677
+196
| +0.6% | +$2.77K |
|
2153
Donnelley Financial Solutions
DFIN
$1.17B
| $442K | ﹤0.01% |
33,131
+100
| +0.3% | +$1.41K |
|
|
CLVS
2154
DELISTED
Clovis Oncology, Inc.
CLVS
| $442K | ﹤0.01% |
29,725
+182
| +0.6% | +$3.29K |
|
2155
Carvana
CVNA
$79.7B
| $440K | ﹤0.01% |
+35,115
| New | +$451K |
|
2156
SunCoke Energy
SXC
$801M
| $440K | ﹤0.01% |
49,565
+487
| +1% | +$4.01K |
|
|
DSPG
2157
DELISTED
DSP Group Inc
DSPG
| $438K | ﹤0.01% |
30,501
+411
| +1% | +$5.92K |
|
|
HABT
2158
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $438K | ﹤0.01% |
41,775
| – | – |
|
2159
Federated Hermes
FHI
$4.7B
| $436K | ﹤0.01% |
13,409
+230
| +2% | +$7.26K |
|
|
SHYF
2160
DELISTED
The Shyft Group
SHYF
| $436K | ﹤0.01% |
39,767
+100
| +0.3% | +$922 |
|
2161
1-800-Flowers.com
FLWS
$262M
| $433K | ﹤0.01% |
22,930
| – | – |
|
2162
Agilysys
AGYS
$3.03B
| $432K | ﹤0.01% |
20,112
+48
| +0.2% | +$996 |
|
2163
Natural Health Trends
NHTC
$15.4M
| $432K | ﹤0.01% |
53,710
+15,999
| +42% | +$167K |
|
|
SEI
2164
Solaris Energy Infrastructure
SEI
$4.07B
| $432K | ﹤0.01% |
28,839
-4,914
| -15% | -$81.5K |
|
|
TDAY
2165
USA Today Co
TDAY
$1.01B
| $431K | ﹤0.01% |
45,606
+100
| +0.2% | +$1K |
|
|
UBP
2166
DELISTED
Urstadt Biddle Properties Inc.
UBP
| $430K | ﹤0.01% |
25,160
-30,026
| -54% | -$517K |
|
2167
Anika Therapeutics
ANIK
$295M
| $429K | ﹤0.01% |
10,553
+20
| +0.2% | +$729 |
|
2168
Pure Cycle
PCYO
$273M
| $429K | ﹤0.01% |
40,488
+52
| +0.1% | +$520 |
|
2169
Canterbury Park Holding Corp
CPHC
$80.8M
| $428K | ﹤0.01% |
34,647
| – | – |
|
2170
Deluxe
DLX
$1.09B
| $426K | ﹤0.01% |
10,474
+91
| +0.9% | +$3.84K |
|
2171
Collegium Pharmaceutical
COLL
$834M
| $423K | ﹤0.01% |
32,162
+65
| +0.2% | +$869 |
|
|
SNR
2172
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $423K | ﹤0.01% |
62,945
+387
| +0.6% | +$2.38K |
|
2173
Signet Jewelers
SIG
$3.59B
| $420K | ﹤0.01% |
23,517
+100
| +0.4% | +$2.15K |
|
2174
Varex Imaging
VREX
$778M
| $420K | ﹤0.01% |
13,697
+111
| +0.8% | +$3.39K |
|
2175
LeMaitre Vascular
LMAT
$1.88B
| $419K | ﹤0.01% |
14,963
| – | – |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.